Tudor Investment Corp’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-11,000
Closed -$138K 1457
2013
Q3
$138K Buy
+11,000
New +$146K 0.01% 765

Tudor Investment Corp's OPTR Position: Q4 2013 in Review

Tudor Investment Corp sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 11,000 shares — an estimated $138K sold.

Tudor Investment Corp first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $138K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Tudor Investment Corp reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Tudor Investment Corp sold 11,000 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $138K.
  • Tudor Investment Corp first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Tudor Investment Corp's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $138K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Tudor Investment Corp's 13F filing for Q4 2013, filed 14 Feb 2014.